Zelluna Immunotherapy announces investment from Takeda Ventures, Inc.
Zelluna Immunotherapy, a company focused on allogenic T-cell Receptor Natural Killer (TCR-NK) cells to treat…
August 25, 2022 - 2 minutes
Cell therapy
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
Gene therapies for lung cancer identified by international team of scientists
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international…
August 24, 2022 - 2 minutes
Sponsored
by ProteoGenix
Optimizing bioproduction using transient expression systems
During drug development, biologics often fail to transition from the preclinical to the clinical stage,…
August 16, 2022 - 7 minutes
Stem cell therapy to be used in treatment of long COVID by Panacell Biotech
A South Korean biotech company says it will use natural killer (NK) cells, exosomes and…
August 10, 2022 - 3 minutes
Allogenic immune cell therapies to be developed as three groups join forces
Three entities have joined forces to develop allogenic immune cell therapies based on a platform…
August 8, 2022 - 3 minutes
RoslinCT and Lykan Bioscience combine to create cell therapy CDMO
RoslinCT, a cell and gene therapy contract development and manufacturing organization (CDMO) developing life-changing therapies…
August 4, 2022 - 2 minutes
Enrollment completed for trial looking at treatment of diabetic kidney disease
Enrollment has been completed for a study of a regenerative cell therapy investigational product for…
August 2, 2022 - 2 minutes
Clinical hold on trial for colorectal cancer drug lifted by FDA
A clinical hold has been lifted by the US Food and Drug Administration (FDA) on…
August 1, 2022 - 2 minutes
T-cell therapy company AlloVir set to raise $126.6M
AlloVir, Inc., a late clinical-stage allogeneic T-cell immunotherapy company, has entered into a securities purchase…
July 27, 2022 - 2 minutes
Oxford Biomedica sets up new project and signs LSA
Oxford Biomedica plc, a UK-based gene and cell therapy group, has initiated a new project…
July 26, 2022 - 4 minutes
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach,…
July 22, 2022 - 7 minutes
Consortium awarded €4M towards platform for personalized cell therapies
A company developing precision T cell therapies that treat solid tumors announced yesterday (July 21)…
July 22, 2022 - 4 minutes
